Most people know cigarettes cause lung cancer. Far fewer know that cigarettes are also one of the leading causes of a cancer that is, statistically, even more lethal — pancreatic cancer. It is diagnosed late, it moves fast, and it kills the great majority of the people who develop it. It is also, in about one of every four cases, a smoking disease. When a family loses someone to pancreatic cancer after a lifetime of smoking, the same industry conduct that drives lung cancer and heart disease claims is usually sitting in the background — a product designed to be addictive, sold with concealed knowledge of its dangers.
This piece extends the firm's series on the smoking-caused cancers the public rarely hears about — alongside our guides to bladder cancer, esophageal cancer, and laryngeal and throat cancer — by explaining a disease that belongs on that list and almost never makes it into the conversation. It covers what pancreatic cancer is, why it sits on the Surgeon General's smoking list, how large the risk really is, why so many of these matters are wrongful death cases, the alternative-causation defense the tobacco companies raise, and how a smoking-related pancreatic cancer claim fits the same liability framework the firm uses in its lung cancer, COPD, and heart disease matters.
What Pancreatic Cancer Is — and Why It Is So Often Caught Late
The pancreas is a small organ tucked deep in the abdomen, behind the stomach, that makes digestive enzymes and the hormones (including insulin) that regulate blood sugar. Most pancreatic cancer is pancreatic ductal adenocarcinoma — a tumor that begins in the cells lining the ducts of the organ. Because the pancreas sits so deep in the body, and because early tumors cause vague or no symptoms, the disease is usually advanced by the time it is found. Jaundice, unexplained weight loss, back or abdominal pain, and new-onset diabetes are the kinds of signals that finally lead to diagnosis, and by then the cancer has often already spread.
That late-diagnosis problem is the reason pancreatic cancer is among the most fatal of all cancers. According to the National Cancer Institute's SEER program, the five-year relative survival for pancreatic cancer is only about 13 percent — roughly one in eight — far below the survival figures for most other common cancers. For legal purposes, that grim statistic has a direct consequence: a large share of smoking-related pancreatic cancer matters are brought not by living patients but by the families they leave behind.
Why Pancreatic Cancer Is on the Surgeon General's Smoking List
The link between smoking and pancreatic cancer is not a plaintiff's theory. It is the conclusion of the United States government's highest scientific authority on tobacco. The 2004 Surgeon General's report, The Health Consequences of Smoking, was the report that formally added pancreatic cancer to the list of diseases for which the evidence is sufficient to infer a causal relationship with cigarette smoking. The landmark 2014 Surgeon General's report, 50 Years of Progress, reaffirmed that conclusion. The Centers for Disease Control and Prevention lists pancreatic cancer among the cancers associated with tobacco use, and the American Cancer Society estimates that about 25 percent of pancreatic cancers are caused by cigarette smoking.
The biology behind that conclusion is understood. Cigarette smoke is not a single chemical but a mixture of dozens of established carcinogens — including tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons. These compounds are absorbed into the bloodstream and reach the pancreas, where they and their metabolites damage the DNA of pancreatic duct cells, driving the mutations that turn a normal cell cancerous. The pancreas does not have to touch smoke directly, the way the lungs or throat do, for the carcinogens in that smoke to reach it and do their damage. That is the same blood-borne pathway that explains why smoking also causes cancers of the bladder and the blood-forming system.
How Big Is the Smoking Risk?
Roughly double, and larger the more and the longer a person smoked. The plain-language figure comes from the American Cancer Society, which states that the risk of pancreatic cancer is about twice as high in people who smoke as in those who never smoked. Behind that headline number is a consistent body of research:
- CDC surveillance data place the relative risk of pancreatic cancer associated with tobacco use in the range of two to four times that of nonusers, grouping it with the cancers the agency tracks as tobacco-associated.
- A large pooled analysis from the Pancreatic Cancer Cohort Consortium, combining data from multiple prospective studies, found current smokers had roughly 1.77 times the risk of never smokers — and that the elevated risk persisted for years after diagnosis-relevant exposure. A separate meta-analysis of the world literature reported a closely matching current-smoker odds ratio of about 1.74.
- The risk follows a dose-response pattern. In the Multiethnic Cohort Study, the excess risk rose steadily with cumulative smoking, with roughly 50 pack-years of smoking associated with about a 91 percent increase in pancreatic cancer risk — the kind of "the more you smoke, the higher the risk" gradient epidemiologists rely on to separate genuine causation from coincidence.
- There is a hopeful mirror image in the same data: quitting lowers the risk. The Multiethnic Cohort found the excess risk fell with each year since quitting and dropped considerably after about 10 years of cessation, and the American Cancer Society confirms that pancreatic cancer risk declines once a person stops smoking. That fact underscores a hard truth in these cases — for many people the disease was, in part, preventable, had the danger been understood and acted on in time.
Those numbers put pancreatic cancer squarely among the diseases cigarettes are known to cause. A person does not have to develop lung cancer for smoking to have taken a fatal toll.
The Human Cost — Why So Many of These Are Wrongful Death Cases
Because pancreatic cancer is caught late and survived rarely, smoking-related pancreatic cancer matters arrive most often as wrongful death cases, brought by a spouse, children, or estate after a loved one has died — frequently within months of the diagnosis. The compressed timeline is its own hardship: families are absorbed in hospice, treatment decisions, and grief at exactly the moment a legal deadline may be running. Our wrongful death family guide walks through what a family in that situation should know, and why acting sooner rather than later matters so much when the disease moves this fast.
The "It Could Have Been Anything" Defense — and Why It Does Not End the Case
Pancreatic cancer has more than one risk factor, and tobacco defendants know it. Expect the familiar move: point to something other than the cigarettes. He had diabetes. There was chronic pancreatitis. He was overweight. There was a family history. Pancreatic cancer often has no known cause at all. The argument trades on the fact that type 2 diabetes, chronic pancreatitis, obesity, heavy alcohol use, certain inherited syndromes, and age do genuinely contribute to pancreatic cancer risk. It does not survive scrutiny.
The reason is that the presence of other risk factors does not erase the one the government has singled out as a cause. Smoking does not act in isolation — and one of the defense's favorite talking points, diabetes, actually cuts the other way in a subtle but important respect: new-onset diabetes in an older adult can be an early sign of an already-developing pancreatic cancer rather than its cause, so a defense that waves at "his diabetes" may be pointing at a symptom of the very tumor at issue. In product-liability law, a manufacturer whose product was a substantial contributing factor to an injury does not escape responsibility merely by naming another factor that also played a part. Pointing to a smoker's weight or family history does not answer why a known carcinogen was delivered to the pancreas, year after year, by an addictive product sold without honest warning.
This is the kind of record where the firm's Medical-Legal Expert earns his place. Herb Borroto, M.D., J.D., who holds both a medical degree and a law degree, reads the imaging, the pathology, the diabetes and pancreatitis history, and the smoking record together — separating the parts of the causal story that support a claim from the parts a defense expert will attack, in a way a purely legal review has no reason to frame and a purely clinical review has no reason to connect to liability.
The Legal Framework
Smoking-related pancreatic cancer cases proceed on the same liability theories as other smoking-disease cases against the tobacco industry:
- Negligent design, manufacture, and marketing of cigarettes.
- Strict product liability for an unreasonably dangerous product.
- Failure to warn about the full range of cancers smoking causes — including cancers, like pancreatic cancer, of organs that never touch the smoke directly.
- Fraud and misrepresentation about the safety and addictiveness of the products.
- Civil conspiracy among manufacturers to suppress and distort health research.
The internal industry records unearthed in prior tobacco litigation — the documents showing what the companies knew about the harms of their product and when — remain central evidence. Our companion piece on how tobacco companies hid the truth walks through that record. Alex Alvarez, the firm's Managing Partner and a Board Certified Civil Trial Lawyer, brings that documentary history together with each client's own smoking and medical records to build the causation case a pancreatic cancer claim requires — including the answer to the "it could have been anything" defense described above. The carcinogen science here overlaps closely with the firm's lung cancer cases and its other smoking-caused cancer matters.
What a Pancreatic Cancer Case Needs
- Documentation of the diagnosis — the imaging (CT, MRI, or endoscopic ultrasound), the biopsy or surgical pathology confirming pancreatic cancer and its type, and the staging.
- A substantial smoking history, measured in pack-years.
- Brand identification — which cigarettes were smoked, and for how long.
- The medical history that bears on the other recognized risk factors — diabetes and its onset date, any chronic pancreatitis, weight, alcohol use, and family history — so those factors can be accounted for rather than left as an open door for the defense.
- Causation testimony from an appropriate expert familiar with the smoking–pancreatic cancer literature.
- Documentation of the disease's impact — the treatment, the decline, and, in the many cases brought after a death, the cause-of-death records and the disease-course documentation.
The unglamorous paperwork behind these elements is what carries a case. Our guide to smoking history documentation covers the records that build or break a tobacco claim — and because pancreatic cancer so often takes a life quickly, gathering those records early is especially important.
The Jurisdictions We Serve
The Alvarez Law Firm represents smokers and families in Hawaii, Illinois, Nevada, Oregon, Pennsylvania, and the U.S. Virgin Islands. Each of those jurisdictions has its own filing deadlines, its own substantive law on tobacco product liability, and its own version of the discovery rule — how long after a diagnosis, or a death, a claim must be filed. Because pancreatic cancer is diagnosed late and progresses quickly, the window to act is often short and the legal deadline is easy to overlook while a family is consumed by care and grief. Talk to counsel licensed in the relevant state about how those deadlines apply to your situation. Waiting can foreclose options that were available earlier.
Frequently Asked Questions
Does smoking cause pancreatic cancer?
Yes. The U.S. Surgeon General has concluded that the evidence is sufficient to infer a causal relationship between cigarette smoking and pancreatic cancer, a conclusion first reached in the 2004 report and reaffirmed since. The CDC includes pancreatic cancer among the cancers associated with tobacco use, and the American Cancer Society estimates that about 25 percent of pancreatic cancers are caused by cigarette smoking. Cigarette smoke carries carcinogens that reach the pancreas through the bloodstream and damage the DNA of pancreatic cells.
How much does smoking raise the risk of pancreatic cancer?
According to the American Cancer Society, the risk of pancreatic cancer is about twice as high in people who smoke as in those who never smoked, and CDC surveillance data place the relative risk associated with tobacco use in the range of two to four times. A large pooled analysis from the Pancreatic Cancer Cohort Consortium found current smokers had roughly 1.77 times the risk of never smokers, and the risk rises with the number of pack-years smoked.
Can you file a lawsuit for smoking-related pancreatic cancer?
Potentially. A smoking-caused pancreatic cancer proceeds on the same product-liability theories as other tobacco-disease claims, including negligent design and marketing, strict product liability, failure to warn, fraud, and civil conspiracy. Because pancreatic cancer is often fatal, many of these are wrongful death cases brought by surviving family members. Every jurisdiction has its own filing deadline, so a longtime smoker diagnosed with pancreatic cancer, or a family that lost someone to it, should speak with counsel licensed in the relevant state promptly.
If You or a Family Member Has Been Diagnosed
If you have a substantial smoking history and have been diagnosed with pancreatic cancer — or your family lost a loved one to it — a free, confidential case review is the right next step. The same conversation that produces a viable lung cancer case can produce a viable pancreatic cancer case, and because this disease moves so quickly, starting that conversation early matters more here than almost anywhere else.
- Read about the firm's other smoking-caused cancer cases: Bladder Cancer, Esophageal Cancer, and Laryngeal and Throat Cancer.
- Read the wrongful death family guide: Smokers Wrongful Death Family Guide.
- Learn how the industry concealed the harms: How Tobacco Companies Hid the Truth.
Free case review. No fees unless we recover compensation for you.
Sources
- U.S. Surgeon General — "The Health Consequences of Smoking: A Report of the Surgeon General" (2004), which concluded the evidence is sufficient to infer a causal relationship between smoking and pancreatic cancer; reaffirmed in "50 Years of Progress" (2014). cdc.gov/tobacco/sgr
- American Cancer Society — "Pancreatic Cancer Risk Factors," stating pancreatic cancer risk is about twice as high in smokers and that about 25% of pancreatic cancers are thought to be caused by smoking, with risk declining after quitting. cancer.org
- Centers for Disease Control and Prevention — "Surveillance for Cancers Associated with Tobacco Use," listing pancreatic cancer among tobacco-associated cancers (relative risk range 2.0–4.0). cdc.gov/mmwr
- Lynch SM, et al. "Cigarette Smoking and Pancreatic Cancer: A Pooled Analysis From the Pancreatic Cancer Cohort Consortium." American Journal of Epidemiology, 2009 — current-smoker odds ratio 1.77. pmc.ncbi.nlm.nih.gov
- Park SL, et al. "Excess pancreatic cancer risk due to smoking and modifying effect of quitting smoking: The Multiethnic Cohort Study." PMC, 2024 — dose-response by pack-years and substantial risk reduction about 10 years after cessation. pmc.ncbi.nlm.nih.gov
- National Cancer Institute, SEER Program — Cancer Stat Facts: Pancreatic Cancer, reporting a five-year relative survival of approximately 13%. seer.cancer.gov